Company Filing History:
Years Active: 2025
Title: The Innovations of Marc L Reitman
Introduction
Marc L Reitman is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of pharmacology, particularly through his work on A1 adenosine receptor agonists. His innovative approach has implications for the treatment and prevention of various diseases.
Latest Patents
Marc L Reitman holds a patent for A1 adenosine receptor agonists and methods of use thereof. This patent discloses compounds that are selective to the A1 adenosine receptor, which are contemplated for use in inducing and maintaining a hypothermic and/or hypometabolic state for the treatment of mammals. The patent includes specific formulas and pharmaceutical compositions that enhance the therapeutic potential of these compounds.
Career Highlights
Reitman is associated with the United States of America, as represented by the Secretary, Department of Health and Human Services. His work has been instrumental in advancing the understanding of adenosine receptors and their role in various medical conditions.
Collaborations
Throughout his career, Marc L Reitman has collaborated with esteemed colleagues such as Kenneth Alan Jacobson and Dilip K Tosh. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Marc L Reitman's contributions to the field of pharmacology through his patent on A1 adenosine receptor agonists exemplify his commitment to advancing medical science. His work continues to influence the development of new therapeutic strategies.